This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Förger, F Articles by Helmke, K Search for Related Content PubMed PubMed Citation Articles by Förger, F Articles by Helmke, K Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis

IV. Department of Internal Medicine, Clinical Immunology and Rheumatology, Hospital Munich-Bogenhausen, Teaching Hospital of the Technical University of Munich, Germany

T Matthias

Aesku Diagnostics, Wendelsheim, Germany

M Oppermann

IV. Department of Internal Medicine, Clinical Immunology and Rheumatology, Hospital Munich-Bogenhausen, Teaching Hospital of the Technical University of Munich, Germany

H Becker

Department of Internal Medicine B, Rheumatology, University of Münster, Germany

K Helmke

IV. Department of Internal Medicine, Clinical Immunology and Rheumatology, Hospital Munich-Bogenhausen, Teaching Hospital of the Technical University of Munich, Germany, klaus.helmke{at}extern.lrz-muenchen.de

The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac). Sera of 202 systemiclupus erythematosus(SLE) patients, 33 patients suffering from other autoimmune diseases and 115 healthy blood donors were analysed for anti-dsDNA antibodies by IgG-, IgA- and IgM-specific ELISA, Farr-assay and CLIF. A subset of 24 SLE patients was investigated in a longitudinal study over a period of one to six years. Disease activity of 105 SLE patients was measured according to the ECLAM score. In the cohort of SLE patients 63% were positivefor the IgG class, 40% for the IgA and 57% for the IgM class specific anti-dsDNA ELISA. Sensitivity (79%) and specificity (99%) for the diagnosis of SLE appeared to be highest for the ELISA measuring all isotypes of anti-dsDNA antibodies. The concentrations of anti- dsDNA isotypesshowed a strong correlationwith disease activity. Analysing the relationship between IgG, IgA and IgM anti-dsDNA antibody isotypes and clinical manifestation, we found a significant associationof the IgM isotypewith cutaneousinvolvementand of the IgG isotypewith lupus nephritis. The IgG/IgM ratio of anti-dsDNA antibodies represented a significant parameter to distinguish patients with lupus nephritis from those without renal involvement. In the longitudinal study, a continuous ratio under 0.8 was associated with absence of renal involvement throughout the investigatedperiod. In conclusion, the evaluationof anti-dsDNA isotypesprovidesa diagnostictool to define subsets within SLE patients with different clinical manifestations. In particular, the IgG/IgM ratio of anti-dsDNA antibodies could be used as a prognostic marker for lupus nephritis during the course of the disease.

Key Words: anti-dsDNA antibodies • immunoglobuline isotypes • lupus nephritis • SLE

Lupus, Vol. 13, No. 1, 36-44 (2004)
DOI: 10.1191/0961203304lu485oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. Burling, J. Ng, H. Thein, J. Ly, M.R. Marshall, and P. Gow Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort Lupus, October 1, 2007; 16(10): 830 - 837. [Abstract] [PDF]

				C. Anzilotti, L. Riente, F. Pratesi, D. Chimenti, A. Delle Sedie, S. Bombardieri, and P. Migliorini IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders Rheumatology, October 1, 2007; 46(10): 1579 - 1582. [Abstract] [Full Text] [PDF]

				D. A. Isenberg, J. J. Manson, M. R. Ehrenstein, and A. Rahman Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology, July 1, 2007; 46(7): 1052 - 1056. [Abstract] [Full Text] [PDF]

				C. Jiang, J. Foley, N. Clayton, G. Kissling, M. Jokinen, R. Herbert, and M. Diaz Abrogation of Lupus Nephritis in Activation-Induced Deaminase-Deficient MRL/lpr Mice J. Immunol., June 1, 2007; 178(11): 7422 - 7431. [Abstract] [Full Text] [PDF]

				A. Buhl, J. H. Metzger, N. H. H. Heegaard, P. von Landenberg, M. Fleck, and P. B. Luppa Novel Biosensor-Based Analytic Device for the Detection of Anti-Double-Stranded DNA Antibodies Clin. Chem., February 1, 2007; 53(2): 334 - 341. [Abstract] [Full Text] [PDF]

				K. Papp, Z. Szekeres, N. Terenyi, A. Isaak, A. Erdei, and J. Prechl On-chip Complement Activation Adds an Extra Dimension to Antigen Microarrays Mol. Cell. Proteomics, January 1, 2007; 6(1): 133 - 140. [Abstract] [Full Text] [PDF]

				G S Alarcon, J Calvo-Alen, G McGwin Jr, A G Uribe, S M A Toloza, J M Roseman, M Fernandez, B J Fessler, L M Vila, C Ahn, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time Ann Rheum Dis, September 1, 2006; 65(9): 1168 - 1174. [Abstract] [Full Text] [PDF]

				A. Rouquette and C Desgruelles Detection of Antibodies to dsDNA: An Overview of Laboratory Assays Lupus, July 1, 2006; 15(7): 403 - 407. [Abstract] [PDF]

				H-P Jaekel, A Trabandt, N Grobe, and E Werle Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis Lupus, June 1, 2006; 15(6): 335 - 345. [Abstract] [PDF]

				L De Rycke, D Baeten, E Kruithof, F Van den Bosch, E M Veys, and F De Keyser The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications Lupus, December 1, 2005; 14(12): 931 - 937. [Abstract] [PDF]

				E Toubi and Y Shoenfeld Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality? Lupus, September 1, 2005; 14(9): 665 - 669. [Abstract] [PDF]

				J. Verma, V. Arora, V. Marwaha, A. Kumar, and N. Das Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus Lupus, April 1, 2005; 14(4): 273 - 279. [Abstract] [PDF]